Examining the predictive capabilities of cardiomyocytes derived from human embryonic stem cells derived cardiomyocytes (hES-CMS) for arrhythmogenic liability testing in a high throughput assay

JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS(2014)

引用 0|浏览21
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要